vaccines

News

Valneva, LimmaTech ally on quest for first Shigella vaccine

Valneva has bolstered its vaccines pipeline with a shot designed to protect against shigellosis – a major global health threat – licensed from LimmaTech Biologics.

News

GSK raises forecasts for 2024, but shares slide

GSK posted a healthy 13% increase in second-quarter sales this morning and raised its forecasts for the year on the back of gains for its cancer and HIV drugs, beating market expectations.

R&D

Health Innovators - Steve Damon

Steven Damon, Micron Biomedical, BIO 2024, microneedles,

News

Jonah Sacha, head of pathobiology at OHSU's National Primate Research Centre

Study points to route for 'one and done' flu vaccine

Scientists in the US have developed a new universal form of influenza vaccine that they say could protect against all strains of the virus – and do away with the annual scramble to match sh

News

US govt gives $176m to Moderna for bird flu vaccine

The US government has signed a $176 million deal with Moderna to develop an mRNA-based pandemic influenza vaccine, as reports emerge of a fifth human case of H5N1 flu linked to ongoing outb

News

GSK goes all-in on CureVac’s mRNA vaccines

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and

Valneva, LimmaTech ally on quest for first Shigella vaccine

GSK raises forecasts for 2024, but shares slide

Health Innovators - Steve Damon

Study points to route for 'one and done' flu vaccine

US govt gives $176m to Moderna for bird flu vaccine

GSK goes all-in on CureVac’s mRNA vaccines

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

vaccines

Editor's Picks